论文部分内容阅读
２４例女性膀胱颈梗阻患者（平均年龄６３±ｓ１４ａ），每晚服用特拉唑嗪２ｍｇ，２ｗｋ后随访，排尿费力消失２３例，膀胱平均残余尿由治疗前１１９±９９ｍＬ减少到治疗后１３±２１ｍＬ，９例平均尿流率和最大尿流率分别由治疗前的４．８±１．４ｍＬ／ｓ及８．９±２．６ｍＬ／ｓ到治疗后的７．６±２．６ｍＬ／ｓ和１８±８ｍＬ／ｓ。该药更适合不愿手术或有手术禁忌的女性膀胱颈梗阻的患者。
Twenty-four patients with bladder neck obstruction (mean age 63 ± s14a) were treated with terazosin 2 mg every night and followed up 2 weeks later. Twenty-three patients lost urination laboriously and the mean bladder residual urine decreased from 119 ± 99 mL before treatment to 13 ± 21 mL, mean flow rate of 9 and maximum flow rate of urine from 4.8 ± 1.4 mL / s and 8.9 ± 2.6 mL / s before treatment to 7.6 ± 2.6 mL / s after treatment And 18 ± 8 mL / s. The drug is more suitable for patients who do not want surgery or contraindications to female bladder neck obstruction.